4//SEC Filing
Robertson Scott M. 4
Accession 0001209191-21-056521
CIK 0001645569other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 9:21 PM ET
Size
36.3 KB
Accession
0001209191-21-056521
Insider Transaction Report
Form 4
Robertson Scott M.
CFO & CBO
Transactions
- Award
Stock Option (right to buy)
2021-09-14+7,191→ 7,191 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (7,191 underlying) - Award
Stock Option (right to buy)
2021-09-14+2,688→ 2,688 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (2,688 underlying) - Award
Stock Option (right to buy)
2021-09-14+16,595→ 16,595 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (16,595 underlying) - Award
Stock Option (right to buy)
2021-09-14+7,500→ 7,500 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (7,500 underlying) - Award
Stock Option (right to buy)
2021-09-14+5,000→ 5,000 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (5,000 underlying) - Award
Stock Option (right to buy)
2021-09-14+20,751→ 20,751 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (20,751 underlying) - Award
Stock Option (right to buy)
2021-09-14+15,000→ 15,000 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (15,000 underlying) - Award
Stock Option (right to buy)
2021-09-14+771→ 771 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (771 underlying) - Award
Stock Option (right to buy)
2021-09-14+9,095→ 9,095 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (9,095 underlying) - Award
Stock Option (right to buy)
2021-09-14+9,750→ 9,750 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (9,750 underlying) - Award
Stock Option (right to buy)
2021-09-14+920→ 920 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (920 underlying) - Award
Stock Option (right to buy)
2021-09-14+20,000→ 20,000 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
2021-09-14+2,500→ 2,500 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (2,500 underlying) - Award
Stock Option (right to buy)
2021-09-14+11,250→ 11,250 totalExercise: $17.00Exp: 2031-09-14→ Common Stock (11,250 underlying)
Holdings
- 216,750
Common Stock
Footnotes (9)
- [F1]The number of shares of Common Stock reported in the Reporting Holder's Form 3 reflected the conversion of derivative securities based on the midpoint of the Issuer's initial public offering range of $16.00 per share. The number of shares of Common Stock reflected in this Form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares.
- [F2]Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
- [F3]The option is fully vested and exercisable.
- [F4]The option vests as to 1/48th of the total shares monthly, beginning December 1, 2017, subject to the Reporting Holder's continuing employment with the Registrant.
- [F5]The option vests as to 1/48th of the total shares monthly, beginning February 28, 2019, subject to the Reporting Holder's continuing employment with the Registrant.
- [F6]The option vests as to 1/48th of the total shares monthly, beginning August 27, 2020, subject to the Reporting Holder's continuing employment with the Registrant.
- [F7]The option vests as to 1/48th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continuing employment with the Registrant.
- [F8]The option vests as to 1/48th of the total shares monthly, beginning August 2, 2021, subject to the Reporting Holder's continuing employment with the Registrant.
- [F9]The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continuing employment with the Registrant.
Documents
Issuer
DICE Therapeutics, Inc.
CIK 0001645569
Entity typeother
Related Parties
1- filerCIK 0001882035
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 9:21 PM ET
- Size
- 36.3 KB